Andrew (andy) M. Badolato

Biography

Mr. Andrew (Andy) M. Badolato is Chairman of the Board and Chief Executive Officer of Industrial Biotechnology Corporation. Mr. Badolato has 22 years of experience in Venture Capital, Technology Transfer, Mergers and Acquisitions (M&A) transactions, Mezzanine and Public equity financings; and in the creation, business development, and oversight of public and private companies. Mr. Badolato has been a co-founder and or early stage investor in 23 plus companies. He was the founder, President and Director of MILCOM Technologies. Mr. Badolato was VP Corporate finance of St James, the founder and intial seed round investors of Inktomi. Mr. Badolato was the founding President and Director of SinoFresh HealthCare, Inc, a developer and marketer of innovative therapies to treat inflammatory and infectious diseases of the upper respiratory system. Mr. Badolato successfully launched the Company's lead product, SinoFresh Nasal, Oral & Sinus Care. Mr. Badolato is a co-founder of Industrial Biotechnology Corporation. He also is Managing Director of White Knights & Vultures LLC., a Venture Capital Hedge Fund. Mr. Badolato graduated from St. Thomas of Villanova University in Miami, Florida, with a Bachelors of Arts in Business.  

Research Interest

Green Biofuels and Energy Green Innovative Trends Environmental Engineering Biobased Chemicals Green synthesis and Designing Waste Management